NCT07277452 2025-12-11
NOTABLE-309
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT06938503 2025-04-22
AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT06422156 2024-05-20
Nim-PC-28
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT06409429 2024-05-10
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Not yet recruiting
NCT06343116 2024-04-02
NOTABLE-308
Biotech Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting